2,808
Participants
Start Date
May 10, 2011
Primary Completion Date
December 18, 2012
Study Completion Date
July 26, 2013
V419
V419 (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate \[Meningococcal Outer Membrane Protein Complex\], and Hepatitis B \[Recombinant\] Vaccine) (from one of three lots) 0.5 mL intramuscular injection at 2, 4, and 6 months of age.
PENTACEL™
PENTACEL™ 0.5 mL intramuscular injection at 15 months of age in the V419 groups and at 2, 4, 6, and 15 months of age in the control group
Prevnar 13™
Prevnar 13™ 0.5 mL intramuscular injection at 2, 4, 6, and 15 months of age
RotaTeq™
RotaTeq™ 2 mL oral dose at 2, 4, and 6 months of age
Recombivax HB vaccine
Recombivax HB vaccine 0.5 mL intramuscular injection at 2 and 6 months of age
Collaborators (1)
MCM Vaccines B.V.
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY